Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Merck Forecasts Global Molnupiravir Revenues Of $5bn-$7bn Through 2022
Oct 28 2021
•
By
Jessica Merrill
Merck forecast billions in revenue coming from molnupiravir • Source: Alamy
More from Earnings
More from Business